Literature DB >> 34117017

Is Contrast Medium Really Needed for Follow-up MRI of Untreated Intracranial Meningiomas?

J Boto1, R Guatta2, A Fitsiori3, J Hofmeister4, T R Meling2, M I Vargas3.   

Abstract

BACKGROUND AND
PURPOSE: Recent concerns relating to tissue deposition of gadolinium are favoring the use of noncontrast MR imaging whenever possible. The purpose of this study was to assess the necessity of gadolinium contrast for follow-up MR imaging of untreated intracranial meningiomas.
MATERIALS AND METHODS: One-hundred twenty-two patients (35 men, 87 women) with meningiomas who underwent brain MR imaging between May 2007 and May 2019 in our institution were included in this retrospective cohort study. We analyzed 132 meningiomas: 73 non-skull base (55%) versus 59 skull base (45%), 93 symptomatic (70%) versus 39 asymptomatic (30%). Fifty-nine meningiomas underwent an operation: 54 World Health Organization grade I (92%) and 5 World Health Organization grade II (8%). All meningiomas were segmented on T1 3D-gadolinium and 2D-T2WI. Agreement between T1 3D-gadolinium and 2D-T2WI segmentations was assessed by the intraclass correlation coefficient.
RESULTS: The mean time between MR images was 1485 days (range, 760-3810 days). There was excellent agreement between T1 3D-gadolinium and T2WI segmentations (P < .001): mean tumor volume (T1 3D-gadolinium: 9012.15 [SD, 19,223.03] mm3; T2WI: 8528.45 [SD, 18,368.18 ] mm3; intraclass correlation coefficient = 0.996), surface area (intraclass correlation coefficient = 0.989), surface/volume ratio (intraclass correlation coefficient = 0.924), maximum 3D diameter (intraclass correlation coefficient = 0.986), maximum 2D diameter in the axial (intraclass correlation coefficient = 0.990), coronal (intraclass correlation coefficient = 0.982), and sagittal planes (intraclass correlation coefficient = 0.985), major axis length (intraclass correlation coefficient = 0.989), minor axis length (intraclass correlation coefficient = 0.992), and least axis length (intraclass correlation coefficient = 0.988). Tumor growth also showed good agreement (P < .001), estimated as a mean of 461.87 [SD, 2704.1] mm3/year on T1 3D-gadolinium and 556.64 [SD, 2624.02 ] mm3/year on T2WI.
CONCLUSIONS: Our results show excellent agreement between the size and growth of meningiomas derived from T1 3D-gadolinium and 2D-T2WI, suggesting that the use of noncontrast MR imaging may be appropriate for the follow-up of untreated meningiomas, which would be cost-effective and avert risks associated with contrast media.
© 2021 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34117017      PMCID: PMC8367609          DOI: 10.3174/ajnr.A7170

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   4.966


  31 in total

1.  U.S. health care spending in an international context.

Authors:  Uwe E Reinhardt; Peter S Hussey; Gerard F Anderson
Journal:  Health Aff (Millwood)       Date:  2004 May-Jun       Impact factor: 6.301

2.  Meningiomas: skull base versus non-skull base.

Authors:  Torstein R Meling; Michele Da Broi; David Scheie; Eirik Helseth
Journal:  Neurosurg Rev       Date:  2018-04-07       Impact factor: 3.042

3.  The natural history of intracranial meningiomas.

Authors:  Soichi Oya; Seon-Hwan Kim; Burak Sade; Joung H Lee
Journal:  J Neurosurg       Date:  2011-01-21       Impact factor: 5.115

4.  Natural history of elderly patients with asymptomatic meningiomas.

Authors:  M Niiro; K Yatsushiro; K Nakamura; Y Kawahara; J Kuratsu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-01       Impact factor: 10.154

5.  Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies.

Authors:  Naoya Hashimoto; Carter S Rabo; Yoshiko Okita; Manabu Kinoshita; Naoki Kagawa; Yasunori Fujimoto; Eiichi Morii; Haruhiko Kishima; Motohiko Maruno; Amami Kato; Toshiki Yoshimine
Journal:  J Neurosurg       Date:  2011-12-16       Impact factor: 5.115

6.  Volumetric analysis of the growth rate of incompletely resected intracranial meningiomas.

Authors:  M Nakamura; F Roser; J Michel; C Jacobs; M Samii
Journal:  Zentralbl Neurochir       Date:  2005-02

7.  High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.

Authors:  Tomonori Kanda; Kazunari Ishii; Hiroki Kawaguchi; Kazuhiro Kitajima; Daisuke Takenaka
Journal:  Radiology       Date:  2013-12-07       Impact factor: 11.105

8.  Typical, atypical, and misleading features in meningioma.

Authors:  M P Buetow; P C Buetow; J G Smirniotopoulos
Journal:  Radiographics       Date:  1991-11       Impact factor: 5.333

9.  Noncontrast T2-Weighted Magnetic Resonance Imaging Sequences for Long-Term Monitoring of Asymptomatic Convexity Meningiomas.

Authors:  Joy Qiyue He; Michael Iv; Gordon Li; Michael Zhang; Melanie Hayden Gephart
Journal:  World Neurosurg       Date:  2019-11-14       Impact factor: 2.104

10.  Computational Radiomics System to Decode the Radiographic Phenotype.

Authors:  Joost J M van Griethuysen; Andriy Fedorov; Chintan Parmar; Ahmed Hosny; Nicole Aucoin; Vivek Narayan; Regina G H Beets-Tan; Jean-Christophe Fillion-Robin; Steve Pieper; Hugo J W L Aerts
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

View more
  4 in total

1.  Do We Need Gadolinium-Based Contrast Agents for Routine MRI Surveillance of Unoperated Pituitary Macroadenoma?

Authors:  A A Alali; P B Hanagandi; P J Maralani
Journal:  AJNR Am J Neuroradiol       Date:  2022-06-23       Impact factor: 4.966

2.  Meningioma in patients exposed to progestin drugs: results from a real-life screening program.

Authors:  Catherine Oppenheim; Joseph Benzakoun; Thomas Samoyeau; Corentin Provost; Alexandre Roux; Laurence Legrand; Edouard Dezamis; Geneviève Plu-Bureau; Johan Pallud
Journal:  J Neurooncol       Date:  2022-09-06       Impact factor: 4.506

3.  Spontaneous regression of a posterior fossa meningioma: A case report.

Authors:  Maya Takada; Kiyoyuki Yanaka; Kazuhiro Nakamura; Ken Akimoto; Hayato Takeda; Eiichi Ishikawa
Journal:  Surg Neurol Int       Date:  2022-08-05

Review 4.  Management of Recurrent Meningiomas: State of the Art and Perspectives.

Authors:  Marco Vincenzo Corniola; Torstein R Meling
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.